Ana gezinime atla
Aramaya atla
Ana içeriğe atla
Bahçeşehir Üniversitesi Yurt içi
English
Türkçe
Yurt içi
Profiller
Araştırma Birimleri
Araştırma Sonucu
Basın / Medya
Uzmanlık alanı, ad ve ilişkiye göre ara
Uzmanla iletişime geçin
Scopus Profilini Görüntüle
Tolga Taşçi
Prof. Dr.
Cerrahi Tip Bilimleri
E-posta
tolga.tasci
med.bau.edu
tr
h-index
501
Alıntılar
14
h-indeks
Scopus alıntıları ve Pure'de kayıtlı yayın sayısına göre hesaplandı
2008
2024
Yıla göre araştırma sonucu
Genel bakış
Parmak izi
Ağ
Araştırma Sonucu
(65)
Basın / Medya
(4)
Benzer Profiller
(6)
Parmak izi
Tolga Taşçi‘in aktif olduğu araştırma başlıklarına git. Bu konu etiketleri bu kişinin eserlerindendir. Birlikte benzersiz bir parmak izi oluştururlar.
Sıralama ölçütü
Ağırlık
Alfabetik sıralama
Medicine and Dentistry
Uterine Cancer
100%
Recurrent Disease
73%
Neoplasm
67%
Retroperitoneal Lymph Node Dissection
50%
Lymph Node Metastasis
41%
Granulosa Cell Tumour
36%
Metastatic Carcinoma
28%
Pelvis
28%
Diseases
27%
Overall Survival
26%
Disease Free Survival
26%
Prognostic Factor
25%
Adjuvant Therapy
20%
Lymph Node
20%
Ovarian Tumor
19%
Gynecological Oncology
19%
Progression Free Survival
19%
Malignant Neoplasm
16%
CA-125
15%
Cervical Cancer
15%
Uterine Serous Carcinoma
14%
Ascites Fluid Cytology
14%
Lymph Duct
13%
Endometrium Carcinoma
11%
Adjuvant Radiotherapy
11%
Hysterectomy
11%
Univariate Analysis
10%
Squamous Cell
10%
Surgery
10%
Disease Specific Survival
10%
Laparotomy
9%
Radiation Therapy
9%
Vulvar Cancer
9%
Sentinel Lymph Node
9%
Salpingooophorectomy
9%
Multivariate Analysis
9%
Recurrence Risk
9%
Paraaortic Lymph Node
9%
Carcinosarcoma
9%
Neoadjuvant Chemotherapy
9%
Gynecology
8%
Adenocarcinoma
7%
Hyperplasia
7%
Biopsy Technique
7%
Survival Analysis
7%
Survival Rate
6%
Radical Surgery
6%
Clear Cell
6%
Female Genital Tract Cancer
5%
Cytoreductive Surgery
5%
Keyphrases
Endometrial Cancer
70%
Lymphadenectomy
36%
Lymph Node Metastasis
35%
Adult Granulosa Cell Tumor
31%
Disease-free Survival
26%
Tumor
25%
Overall Survival
23%
Endometrioid Endometrial Cancer
22%
Progression-free Survival
21%
Adjuvant Therapy
20%
Metastasis
17%
Tumor Size
17%
Staged Surgery
16%
Endometrioid
15%
Frozen Section
15%
Independent Prognostic Factor
14%
Peritoneal Cytology
14%
Multicentric
14%
Para-aortic Lymphadenectomy
14%
Granular Cell Tumor
13%
Uterine Serous Carcinoma
13%
Single Center
13%
Univariate Analysis
13%
Recurrence Rate
13%
Prognostic Factors
13%
Disease-specific Survival
12%
Multivariate Analysis
12%
Borderline Tumor
12%
Post-recurrence Survival
12%
Follow-up Time
11%
Adjuvant Radiotherapy
11%
Ovarian Tumor
11%
High-risk Endometrial Cancer
11%
Cancer Patients
11%
Endometrial Carcinoma
11%
Carbohydrate Antigen 125 (CA125)
10%
Vulvar Cancer
10%
Lymphovascular Invasion
10%
CA-125 Levels
10%
Salpingo-oophorectomy
10%
Menopausal Status
9%
Residual Tumor
9%
Intermediate Risk
9%
Factors Predicting
9%
Obstetrics
9%
Sentinel Lymph Node
9%
Recurrence Prediction
9%
Gynecologic Surgery
9%
Multi-institutional Analysis
9%
Stage IVB
9%
